Novelix Pharmaceuticals share news, announcements and annual reports
BSE: 536565Healthcare ServicesSmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹71.19.
30 Oct: open ₹71.00, high ₹71.00, low ₹65.65
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹195 Cr2,861st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 53.80
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.09
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,391
Novelix Pharmaceuticals share news and announcements
605 announcements, routine notices left out, newest first. Page 7 of 13.
Mar 2021
Feb 2021
13 Feb · Results
1 Feb · Board meeting
Meeting on 13 Feb 2021: quarterly results
Jan 2021
8 Jan · Shareholding for the Period Ended December 31, 2020
Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....8 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2020
Oct 2020
27 Oct · Board meeting
Meeting on 6 Nov 2020: quarterly results12 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 012 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....
Sep 2020
12 Sep · Announcement Under Regulation 30 (LODR) - Complaint Filed Against Anugrah Stock & Broking Private Limited, Mumbai.
9 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....8 Sep · Meeting
Aug 2020
14 Aug · Board meeting
Meeting on 20 Aug 2020: quarterly results6 Aug · Announcement Under Regulation 30 - Conversion Of The Promoter Company To LLP
Jul 2020
29 Jul · Application For Drug,Food And Ayurvedic License
8 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....8 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2020
10 Jun · Board meeting
Meeting on 18 Jun 2020: audited results
May 2020
11 May · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....
Apr 2020
21 Apr · Compliance With SEBI (Listing Obligations And Disclosure Regulations) Regulations, 2015 (Half Year Ended 31/03/2020)
17 Apr · Declaration With Respect To Non-Applicability Of Disclosure On Related Party Transactions For The Half Year Ended March 31, 2020.
17 Apr · Compliance With SEBI (Listing Obligations And Disclosure Regulations) Regulations, 2015 (Half Year Ended 31/03/2020)
17 Apr · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Feb 2020